PCSK9 and coronary artery disorder: Subsequently, the Atherosclerosis Risk In Community (ARIC) study and other population studies showed that PCSK9 loss-of-function mutations resulted in lower plasma LDL-C levels and a dramatically reduced risk of coronary heart disease (CHD) [8–10].